What is the address of DR. PATRICIA SCHEIDT - GYNAECOLOGIE?

The registered office of DR. PATRICIA SCHEIDT - GYNAECOLOGIE is located at Zelestraat 77, 9160 Lokeren.

Is DR. PATRICIA SCHEIDT - GYNAECOLOGIE still active?

Yes. According to the CBE (1 October 2026) DR. PATRICIA SCHEIDT - GYNAECOLOGIE is active, legal situation “Normale toestand”, started on 25 August 2003.

Is DR. PATRICIA SCHEIDT - GYNAECOLOGIE registered on Peppol?

Yes, DR. PATRICIA SCHEIDT - GYNAECOLOGIE is registered on the Peppol network with ID 0208:0860205797.

What is the enterprise number of DR. PATRICIA SCHEIDT - GYNAECOLOGIE?

The enterprise number of DR. PATRICIA SCHEIDT - GYNAECOLOGIE is BE0860205797.

When was DR. PATRICIA SCHEIDT - GYNAECOLOGIE founded?

DR. PATRICIA SCHEIDT - GYNAECOLOGIE was founded on 25 August 2003.

Who are the directors of DR. PATRICIA SCHEIDT - GYNAECOLOGIE?

According to the 2024 annual accounts, the directors of DR. PATRICIA SCHEIDT - GYNAECOLOGIE are: Patricia SCHEIDT.

Is DR. PATRICIA SCHEIDT - GYNAECOLOGIE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 25 August 2003; 4 annual accounts filed, latest fiscal year 2024; 1 directors known from the annual account.

How much profit did DR. PATRICIA SCHEIDT - GYNAECOLOGIE make in 2024?

DR. PATRICIA SCHEIDT - GYNAECOLOGIE posted a profit after taxes of € 74,791 in financial year 2024.

What is the revenue of DR. PATRICIA SCHEIDT - GYNAECOLOGIE?

As a small company, DR. PATRICIA SCHEIDT - GYNAECOLOGIE is not required to publish revenue in its annual accounts. In financial year 2024, its added value was € 138,261.

DR. PATRICIA SCHEIDT - GYNAECOLOGIE (Private Limited)

Dossier DR. PATRICIA SCHEIDT - GYNAECOLOGIE, printed on 1 October 2026 from databakkes.be/en/0860205797/dr-patricia-scheidt-gynaecologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2024

DR. PATRICIA SCHEIDT - GYNAECOLOGIE from Lokeren, company number BE0860205797, closed financial year 2024 with a result of € 74,791 after tax. For that financial year DR. PATRICIA SCHEIDT - GYNAECOLOGIE recorded a gross margin of € 138,261 and equity of € 855,008. Compared with financial year 2023, the result moved from € 60,530 to € 74,791. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 25, 2025.

What it is worth Growing

€ 855,008

▲ 10% vs 2023

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 74,791

▲ 24% vs 2023

Profit after tax over the fiscal year.

Cash in the bank

€ 244,446

▲ 87% vs 2023

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2024. Retained profit grew to € 411,508.

People and assets in 2024

Vehicles and equipment

€ 68,890

▲ 158% vs 2023

Book value of vehicles, furniture and equipment.

Debts at end 2024

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 20,371

▲ 49% vs 2023

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 8,436

▼ 11% vs 2023

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2021	2022	2023	2024	Change 2023 → 2024
Gross margin	€ 90,428 Gross margin 2021: € 90,428 First fiscal year in the series	€ 88,429 Gross margin 2022: € 88,429 ▼ 2% vs 2021 (€ 90,428) Unfavourable step	€ 108,513 Gross margin 2023: € 108,513 ▲ 23% vs 2022 (€ 88,429) Favourable step	€ 138,261 Gross margin 2024: € 138,261 ▲ 27% vs 2023 (€ 108,513) Favourable step	▲ 27%
Profit after taxes	€ 41,639 Profit after taxes 2021: € 41,639 First fiscal year in the series	€ 50,809 Profit after taxes 2022: € 50,809 ▲ 22% vs 2021 (€ 41,639) Favourable step	€ 60,530 Profit after taxes 2023: € 60,530 ▲ 19% vs 2022 (€ 50,809) Favourable step	€ 74,791 Profit after taxes 2024: € 74,791 ▲ 24% vs 2023 (€ 60,530) Favourable step	▲ 24%
Equity	€ 1,027,643 Equity 2021: € 1,027,643 First fiscal year in the series	€ 773,260 Equity 2022: € 773,260 ▼ 25% vs 2021 (€ 1,027,643) Unfavourable step	€ 780,217 Equity 2023: € 780,217 ▲ 1% vs 2022 (€ 773,260) Favourable step	€ 855,008 Equity 2024: € 855,008 ▲ 10% vs 2023 (€ 780,217) Favourable step	▲ 10%
Total debts	€ 104,970 Total debts 2021: € 104,970 First fiscal year in the series	€ 84,785 Total debts 2022: € 84,785 ▼ 19% vs 2021 (€ 104,970) Favourable step	€ 76,689 Total debts 2023: € 76,689 ▼ 10% vs 2022 (€ 84,785) Favourable step	€ 28,807 Total debts 2024: € 28,807 ▼ 62% vs 2023 (€ 76,689) Favourable step	▼ 62%
Cash	€ 178,169 Cash 2021: € 178,169 First fiscal year in the series	€ 64,775 Cash 2022: € 64,775 ▼ 64% vs 2021 (€ 178,169) Unfavourable step	€ 130,491 Cash 2023: € 130,491 ▲ 101% vs 2022 (€ 64,775) Favourable step	€ 244,446 Cash 2024: € 244,446 ▲ 87% vs 2023 (€ 130,491) Favourable step	▲ 87%
Land & buildings	€ 79,687 Land & buildings 2021: € 79,687 First fiscal year in the series	€ 64,110 Land & buildings 2022: € 64,110 ▼ 20% vs 2021 (€ 79,687) Unchanged	€ 49,259 Land & buildings 2023: € 49,259 ▼ 23% vs 2022 (€ 64,110) Unchanged	€ 57,521 Land & buildings 2024: € 57,521 ▲ 17% vs 2023 (€ 49,259) Unchanged	▲ 17%
Retained profit	€ 584,143 Retained profit 2021: € 584,143 First fiscal year in the series	€ 329,760 Retained profit 2022: € 329,760 ▼ 44% vs 2021 (€ 584,143) Unfavourable step	€ 336,717 Retained profit 2023: € 336,717 ▲ 2% vs 2022 (€ 329,760) Favourable step	€ 411,508 Retained profit 2024: € 411,508 ▲ 22% vs 2023 (€ 336,717) Favourable step	▲ 22%
Dividend	€ 0 Dividend 2021: € 0 First fiscal year in the series	€ 305,191 Dividend 2022: € 305,191 Unchanged (€ 0) Unchanged	€ 53,573 Dividend 2023: € 53,573 ▼ 82% vs 2022 (€ 305,191) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 53,573) Unchanged	▼ 100%
Balance sheet total	€ 1,134,824 Balance sheet total 2021: € 1,134,824 First fiscal year in the series	€ 860,036 Balance sheet total 2022: € 860,036 ▼ 24% vs 2021 (€ 1,134,824) Unchanged	€ 858,675 Balance sheet total 2023: € 858,675 Unchanged (€ 860,036) Unchanged	€ 885,363 Balance sheet total 2024: € 885,363 ▲ 3% vs 2023 (€ 858,675) Unchanged	▲ 3%

Key figures of DR. PATRICIA SCHEIDT - GYNAECOLOGIE, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.

What happened to DR. PATRICIA SCHEIDT - GYNAECOLOGIE?

What happened at DR. PATRICIA SCHEIDT - GYNAECOLOGIE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Sep 25, 2025 New annual accounts for financial year 2024: profit of € 74,791 (▲ 24% vs 2023). filed late Source: NBB ↗
Aug 25, 2003 New establishment in Lokeren. KBO
Aug 25, 2003 Start of the company according to the CBE. KBO
2003 Patricia SCHEIDT became a director. NBB

In short

From € 41,639 profit in 2021 to € 74,791 profit in 2024.

Paid € 104,310 in corporate taxes since 2021.

Best year ever: 2024, with € 74,791 profit.

Paid out € 358,764 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR. PATRICIA SCHEIDT - GYNAECOLOGIE? We notify you, reason included.

Follow DR. PATRICIA SCHEIDT - GYNAECOLOGIE

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Patricia SCHEIDT

DR. PATRICIA SCHEIDT - GYNAECOLOGIE

GIENEES

Behind DR. PATRICIA SCHEIDT - GYNAECOLOGIE is Patricia SCHEIDT. Patricia SCHEIDT is also behind GIENEES.

See the full network in the app

Directors

According to the 2024 annual accounts

Patricia SCHEIDT

Director

Also active at: GIENEES

since 2003

Establishments

Establishment units

Physical locations of this company

Registered office

Zelestraat 77

9160 Lokeren

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.

All companies at this address →

GIENEES same network

€ 127,073 gross margin · 2025

VME van het gebouw te 9160 Lokeren, Zelestraat 77.

Dr. Joke Bulthé

€ 174,919 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0860.205.797
VAT number: BE 0860.205.797
Registered office: Zelestraat 77, 9160 Lokeren
Names & denominations: DR. PATRICIA SCHEIDT - GYNAECOLOGIE
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 25 August 2003
Peppol: Active · Active since 25 Sept 2025

View on CBE Public ↗ Annual accounts (NBB) ↗